The Prostaglandin-Prostacyclin-Nitric Oxide Connection

Sidebar: Highly Cited Nitric Oxide ARticles by Salvador Moncada As part of my keynote address at the 10th International Conference on Prostaglandins and Related Compounds in Vienna on September 22, I reviewed my 1984 analysis of the 1982 Nobel Prize in physiology or medicine that honored the work of Sir John R. Vane, Sune K. Bergstrom, and Bengt I. Samuelsson in advancing prostaglandin research (E. Garfield, Current Contents, 12:3-12, March 19, 1984). This field has grown enormously since then

Written byEugene Garfield
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Sidebar: Highly Cited Nitric Oxide ARticles by Salvador Moncada

For the Vienna talk, we created a file of more than 40,000 papers published from 1981 through 1995 whose titles contained "prostaglandin" and other related key words. These were extracted from the Science Indicators Database of the Philadelphia-based Institute for Scientific Information. We then were able to identify the most-cited authors in this field. One outstanding author is Salvador Moncada, formerly of Wellcome Research Foundation, Beckenham, England, and now at the Cruciform Project for Strategic Medical Research, University College, London.

Moncada's remarkable research accomplishments include participating in the discoveries of inhibition of prostaglandin biosynthesis by aspirin-like drugs, thromboxane synthesis and its inhibitors, and prostacyclin, a prostaglandin that is a metabolite of arachidonic acid. More recently, Moncada and his colleagues discovered the biological role of nitric oxide. In particular, they demonstrated that nitric oxide is released from vascular endothelial cells in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies